Все публикации

2023 Symposium Highlights

Registration is now open for the Milner Therapeutics Symposium 2024!

Milner Consortium Call 2023

Dr Camilla Fairbairn: opti-ox: Transforming the drug discovery, research & cell therapy landscape...

Transforming life science through AI and machine learning

Dr. Ian Roberts: How Healx uses AI to increase the probability of success in drug discovery

Alex Taylor: Engineering artificial oligonucleotide catalysts for precision knockdown of...

Dr Tom Mitchell describes how Milner collaboration has supported his research

Dr Sarah Welsh describes how Milner collaboration has supported her research

Adrian Liston: Design new therapeutics for treating neuroinflammatory disorders

Lifebit: Unlocking the potential of connected clinico-genomic data through Federated...

Introduction to the Milner Therapeutics Institute, by Professor Tony Kouzarides

Omer Bayraktar: Exploring human tissue architecture using high-throughput spatial genomics

Ziad Mallat: Targeting the immune response to treat ischaemic heart disease

Jason Carroll: Mechanisms of estrogen receptor activity in breast cancer

Robin Franklin: Myelin regeneration in the CNS: reversing the ravages of time

Mathew Garnett: Functional genomic approaches to guide cancer drug discovery

Mike Romanos: Precision Microbiome Science Enables Best in Class Therapeutics

What people think about our annual Symposium

Connect: Health Tech - Hybrid Events: unlocking the potential of your content and creating success

Milner Careers

Consortium Call 2022

RNA modifications detection by comparative Nanopore direct RNA sequencing.

OBN Awards 25/11/21